Altered excitatory and inhibitory neuronal subpopulation parameters are distinctly associated with tau and amyloid in Alzheimer's disease
Kamalini G. RanasingheiD, Parul VermaiD, Chang CaiiD, Xihe XieiD, Kiwamu KudoiD, Xiao GaoiD, Hannah LerneriD, Danielle MizuiriiD, Amelia StromiD, Leonardo IaccarinoiD, Renaud La JoieiD, Bruce L. MilleriD, Maria Luisa Gorno‐TempiniiD, Katherine P. RankiniD, William J. JagustiD, Keith A. VosseliD, Gil Dan RabinoviciiD, Ashish RajiD, Srikantan S. NagarajaniD
Abstract
BackgroundNeuronal and circuit level abnormalities of excitation and inhibition are shown to be associated with tau and amyloid-beta (A{beta}) in preclinical models of Alzheimers disease (AD). These relationships remain poorly understood in patients with AD. MethodsUsing empirical spectra from magnetoencephalography (MEG) and computational modeling (neural mass model; NMM) we examined excitatory and inhibitory parameters of neuronal subpopulations and investigated their specific associations to regional tau and A{beta}, measured by positron emission tomography (PET), in patients with AD. ResultsPatients with AD showed abnormal excitatory and inhibitory time-constants and neural gains compared to age-matched controls. Increased excitatory time-constants distinctly correlated with higher tau depositions while increased inhibitory time-constants distinctly correlated with higher A{beta} depositions. ConclusionsOur results provide critical insights about potential mechanistic links between abnormal neural oscillations and cellular correlates of impaired excitatory and inhibitory synaptic functions associated with tau and A{beta} in patients with AD. FundingThis study was supported by the National Institutes of Health grants: K08AG058749 (KGR), F32AG050434-01A1 (KGR), K23 AG038357 (KAV), P50 AG023501, P01 AG19724 (BLM), P50-AG023501 (BLM & GDR), R01 AG045611 (GDR); AG034570, AG062542 (WJ); NS100440 (SSN), DC176960 (SSN), DC017091 (SSN), AG062196 (SSN); a grant from John Douglas French Alzheimers Foundation (KAV); grants from Larry L. Hillblom Foundation: 2015-A-034-FEL and (KGR); 2019-A-013-SUP (KGR); a grant from the Alzheimers Association: (PCTRB-13-288476) (KAV), and made possible by Part the CloudTM, (ETAC-09-133596); a grant from Tau Consortium (GDR & WJJ), and a gift from the S. D. Bechtel Jr. Foundation.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 121
- FWCI
- 15.15
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Revealing the combined roles of Aβ and tau in Alzheimer's disease via a pathophysiological activity decoder
Lazaro M. Sanchez-Rodriguez, Gleb Bezgin, … Yasser Iturria‐Medina·bioRxiv·Feb 21, 2023
- Whole-brain modeling of the differential influences of Amyloid-Beta and Tau in Alzheimer's Disease
Gustavo Patow, Leon Stefanovski, … Alzheimer’s Disease Neuroimaging Initiative·Alzheimer s Research & TherapyPeer-reviewed·Dec 5, 2023
- A mechanistic model explains oscillatory slowing and neuronal hyperactivity in Alzheimer's disease
Christoffer G. Alexandersen, Willem de Haan, … Alain Goriely·bioRxiv·Jun 20, 2022
- Combining Aperiodic 1/f Slopes and Brain Simulation: An EEG/MEG Proxy Marker of Excitation/Inhibition Imbalance in Alzheimer's Disease
Pablo Martínez‐Cañada, Eduardo Perez‐Valero, … Christian A. Morillas·Alzheimer s & Dementia Diagnosis Assessment & Disease MonitoringPeer-reviewed·Jul 1, 2023
- Medial amygdalar tau is associated with anxiety symptoms in preclinical Alzheimer's disease
Joyce S Li, Samantha M Tun, … Carolyn A. Fredericks·bioRxiv·Jun 3, 2024
- A multiscale closed-loop neurotoxicity model of Alzheimer's disease progression explains functional connectivity alterations
Jesús Cabrera-Álvarez, Leon Stefanovski, … Petra Ritter·eNeuroPeer-reviewed·Apr 1, 2024